Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* older than 18 years (of both sexes)~* diagnosed with stable chronic heart failure NYHA class II-III~* ejection fraction \< 40 % as assessed by 2D echocardiography~* who have been optimized on Guideline Directed treatment for heart failure for at least a month prior to enrolling.~Exclusion Criteria:~* Known hypersensitivity to statin~* Treatment with statins during the past month prior to study.~* Serum creatinine \> 3 mg/dl~* Significant liver disease: liver enzymes 2.5 folds the upper normal limit~* Malignancy~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Lipophilic statin (Type: ACTIVE_COMPARATOR): Atorvastatin 40 mg administered daily in addition to guideline directed therapy for heart failure.
- Hydrophilic statin (Type: ACTIVE_COMPARATOR): Rosuvastatin 20 mg administered daily in addition to guideline directed therapy for heart failure.

Based on this trial design, predict the completion outcome and termination type (if applicable).